Ready to Take Your Pharmacy Further?
Request Software Demo

BACK to MAIN PAGE

Tennessee

(All States)

Pharmacy Laws & Regulations

Tennessee

Pharmacy Laws & Regulations

(All States)

Image of PioneerRx Drive-thru App icon

Meet the Hosts

Terry Grinder | Interim Executive Director
665 Mainstream Dr Nashville, TN 37243

Meet the Hosts

Section divider image
Q&A Icon
SIGNED INTO LAW
Bill in progress
nEWS UPDATE

Ivermectin Available Without a Prescription

Tennessee Governor Bill Lee (R) recently signed a new law, SB 2188, that allows pharmacists to dispense ivermectin without a prescription and protects them from medical liability. Ivermectin, an antiviral drug used to treat COVID-19, has not received FDA approval or emergency use authorization. Even still, the Tennessee Senate voted in favor of SB 2188 66-20, and the House voted 22-6. In effect, SB 2188 not only allows pharmacists to dispense ivermectin, but it also requires the Board of Pharmacy to establish risk assessment screenings and a fact sheet for pharmacies.

Source:  

FOX 17

Read Full Article
Q&A Icon
SIGNED INTO LAW
Bill in progress
nEWS UPDATE

Tennessee Tightens PBM Regulations With 2 New Bills

Two new PBM bills, SB 258 and HB 2661, are moving through the Tennessee legislature. Both bills would build upon recent PBM reform in the state, requiring transparent and evidence-based reimbursements for pharmacies. New amendments would prohibit PBMs from banning pharmacies from certain networks and reimbursing affiliated pharmacies at higher rates than non-affiliated pharmacies. SB 2458 has been recommended for passage by the Senate Commerce and Labor Committee, and HB 2661 has been recommended for passage by the House Insurance Committee and the House Government Operations Committee.

Source:  

NCPA

Read Full Article
Q&A Icon
SIGNED INTO LAW
Bill in progress
nEWS UPDATE

Tennessee Gov. Enacts Law to Protect 340B Covered Entities from Discriminatory Reimbursement Practices

Tennessee Gov. Lee signed SB 1617/HB 1398 which prohibits PBMs from reimbursing pharmacies below acquisition costs, addresses the issue of patient-steering, prohibits spread pricing in the commercial market, and bans discriminatory payments for 340B prescription dispensing.

Source:  

Community Voices

Read Full Article